Contribution of Myelin Content to the PET-Measured Amyloid Burden.

Authors

Liangdong Zhou, Samantha Keil, Xiuyuan H Wang, Seyed Hani Hojjati, Carmen Barrios Castellanos, Krista M Wartchow, William J Dartora, Laura Beth Mclntire, Gloria C Chiang, Yi Li, Tracy A Butler

Published in

Journal of nuclear medicine : official publication, Society of Nuclear Medicine. Aug 13, 2026. Epub Aug 13, 2026.

Abstract

Off-target binding to white matter myelin is well established in amyloid-β (Aβ) PET. Whether tracer binding to intracortical myelin influences cortical PET quantification remains unknown. We tested whether accounting for myelin water fraction (MWF), an MRI measure of myelin, improves the correlation between Aβ PET and the Alzheimer disease (AD) plasma biomarker phosphorylated tau 217 (p-tau217). Methods: This study included 114 participants with and without AD who underwent Aβ PET with ¹¹C-Pittsburgh compound B (n = 60) or ¹⁸F-florbetaben (n = 54), multiecho fast T2 MRI to quantify MWF, and semiquantitative in vitro diagnostic immunoassay to measure plasma p-tau217 levels. Cortical Aβ burden was quantified using SUV ratio and Centiloids. Nested regression models predicted PET signal using age and p-tau217 level, with and without cortical MWF. Results: MWF independently predicted PET-measured Aβ signal and improved model fit by approximately 6% in both the combined and tracer-specific cohorts. Conclusion: Intracortical myelin contributes to Aβ PET signal. Incorporating MWF may improve Aβ PET quantification, with implications for AD diagnosis, patient selection, and monitoring response to anti-Aβ therapies.

PMID:
42595483
Bibliographic data and abstract were imported from PubMed on 14 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.